X-linked Hypophosphatemia
14 competing products in clinical development for X-linked Hypophosphatemia.
Pipeline by Phase
Pre-clinical2
Phase 11
Phase 1/23
Phase 23
Phase 35
All Products (14)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| burosumab + Oral Phosphate Supplement + active vitamin D | Kyowa Kirin | Phase 3 | Completed | 40 |
| burosumab | Kyowa Kirin | Phase 3 | Completed | 40 |
| Burosumab | Kyowa Kirin | Phase 3 | Completed | 40 |
| Burosumab | Kyowa Kirin | Phase 3 | Completed | 40 |
| burosumab | Kyowa Kirin | Phase 3 | Completed | 40 |
| KK8123 | Kyowa Kirin | Phase 1/2 | Recruiting | 39 |
| Burosumab | Kyowa Kirin | Phase 2 | Completed | 35 |
| burosumab | Kyowa Kirin | Phase 2 | Completed | 35 |
| KRN23 | Kyowa Kirin | Phase 2 | Completed | 35 |
| KRN23 | Kyowa Kirin | Phase 1/2 | Completed | 32 |
| KRN23 | Kyowa Kirin | Phase 1/2 | Completed | 32 |
| Burosumab | Kyowa Kirin | Pre-clinical | Active | 30 |
| Placebo + KRN23 | Kyowa Kirin | Phase 1 | Completed | 29 |
| Burosumab | Kyowa Kirin | Pre-clinical | Completed | 26 |